Skip to main content

Vaccine poses upside risk to forecasts

Commodity prices benefitted from news of a potential vaccine for COVID-19 this week. The resulting boost to risk appetite pushed equities and most commodity prices higher, with the exception of precious metals. That said, while a vaccine points to generally stronger commodities demand, there is still considerable uncertainty over the production and distribution of any vaccine. Nevertheless, the risks to our industrial commodity price forecasts now lie to the upside. Markets will be looking forward to the release of China’s activity data next week. We suspect that the data will show continued strength in industrial production in October, which will support industrial metals prices. Markets will probably also be keeping a close eye on the number of new confirmed cases of COVID-19 in the US. If the ongoing rise leads to additional containment measures, oil prices may fall back.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services


Get access